EYLEA HD
aflibercept
- Strength
- 8 mg/.07mL
- Form
- Injection, Solution
- Class
- Vascular Endothelial Growth Factor Inhi…
Regeneron Pharmaceuticals, Inc
Not stocked by us — reference only
aflibercept
Listed by Regeneron Pharmaceuticals, Inc.
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravitreal |
| Drug class | Vascular Endothelial Growth Factor Inhibitor |
| Approval route | BLA — biologic licence |
| NDC code | 61755-005 |
| FDA application | BLA125387 |
| RxNorm concept | 1232154 |
| Package sizes listed | 4 |
| Marketed since | November 2011 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
aflibercept
Regeneron Pharmaceuticals, Inc
Not stocked by us — reference only
aflibercept
Regeneron Pharmaceuticals, Inc
Not stocked by us — reference only
aflibercept-ayyh
Amgen, Inc
Not stocked by us — reference only
aflibercept-ayyh
Amgen, Inc
Not stocked by us — reference only
aflibercept-jbvf
Biocon Biologics Inc.
Not stocked by us — reference only
ziv-aflibercept
sanofi-aventis U.S. LLC
Not stocked by us — reference only
ziv-aflibercept
sanofi-aventis U.S. LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.